eUrogenis
ActiveeUrogenis has been active since 2013 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €286k and a net result of €155k. Equity is growing by ~8.6% per year across the filed fiscal years. Its solvency ranks better than 47% of 16459 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
92
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100▲+4
Solvency85▼-7
Growth78▲+26
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days acceptable
Liquidity ample (current ratio 2.19 against 2.52 in 2024; short-term debt: 33.2% and cash: 57.4% of total assets), and 40% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
60%
Return on assets
32.4%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
31 d late
2024
30 d late
2023
30 d late
2022
31 d late
2021
31 d late
2020
31 d late
2019
31 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
18-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€286k=
2024 · €286k
2019: €152k
2020: €217k
2021: €224k
2022: €246k
2023: €280k
2024: €286k
2019 → 2025
Total assets
€477k▲ 10.9%
2024 · €431k
2019: €412k
2020: €292k
2021: €305k
2022: €324k
2023: €397k
2024: €431k
2019 → 2025
Net result
€155k▲ 62.1%
2024 · €96k
2019: €107k
2020: €87k
2021: €72k
2022: €109k
2023: €81k
2024: €96k
2019 → 2025
Working capital
€189k▲ 15.8%
2024 · €164k
2019: €95k
2020: €172k
2021: €171k
2022: €127k
2023: €163k
2024: €164k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€224k-€246k▲ 10.0%€280k▲ 13.8%€286k▲ 2.2%€286k=
Operating result€98k-€152k▲ 55.5%€120k▼ 21.4%€126k▲ 4.8%€207k▲ 65.1%
Net result€72k-€109k▲ 51.8%€81k▼ 25.5%€96k▲ 17.5%€155k▲ 62.1%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 65% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €477k
Fixed assets
€129k▼ 18.7%
Current assets
€348k▲ 28.2%
Equity and liabilities €477k
Equity
€286k=
Debt
€191k▲ 32.5%
The debt ratio rises from 33.5% to 40.0%. Debt is higher.
Key figures and ratios
EBITDA
€248k▲
2024 · €161k
Cash flow
€196k▲
2024 · €131k
Solvency
60.0%▼
2024 · 66.5%
Current ratio
2.19▼
2024 · 2.52
Quick ratio
2.19▼
2024 · 2.52
Debt / equity
0.67▲
2024 · 0.50
ROE
54.1%▲
2024 · 33.3%
ROA
32.4%▲
2024 · 22.2%
Interest coverage
136.35▲
2024 · 59.74
Debt
€191k▲
2024 · €144k
Debt ≤ 1 year
€159k▲
2024 · €108k
Debt > 1 year
€32k▼
2024 · €36k
Income taxes
€52k▲
2024 · €27k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€431k€477k▲
Fixed assets21/28€159k€129k▼
Tangible fixed assets22/27€159k€129k▼
Land and buildings22€59k€54k▼
Plant, machinery and equipment23€17k€16k▼
Furniture and vehicles24€83k€60k▼
Current assets29/58€271k€348k▲
Amounts receivable within one year40/41€31k€22k▼
Trade receivables40€1k€0▼
Other amounts receivable41€29k€22k▼
Current investments50/53€50k€52k▲
Cash at bank and in hand54/58€191k€274k▲
Equity and liabilities
Total equity and liabilities10/49€431k€477k▲
Equity10/15€286k€286k=
Contributions10/11€19k€19k=
Capital10€19k-
Issued capital100€19k-
Reserves13€268k€268k=
Distributable reserves133€268k€268k=
Profit (loss) carried forward14-€0
Amounts payable17/49€144k€191k▲
Amounts payable after more than one year17€36k€32k▼
Financial debts170/4€36k€32k▼
Amounts payable within one year42/48€108k€159k▲
Current portion of amounts payable after more than one year42€4k€4k▲
Trade debts44€9k€1k▼
Suppliers440/4€9k€1k▼
Taxes, remuneration and social security45-€22k
Taxes450/3-€22k
Other amounts payable47/48€96k€131k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€35k€41k▲
Other operating charges640/8€595€8k▲
Gross operating margin9900€162k€256k▲
Operating profit (loss)9901€126k€207k▲
Financial income75/76B€1€2k▲
Recurring financial income75€1€2k▲
Non-recurring financial income76B€1€0▼
Financial charges65/66B€3k€2k▼
Recurring financial charges65€3k€2k▼
Profit (loss) for the period before taxes9903€123k€207k▲
Income taxes67/77€27k€52k▲
Profit (loss) for the period9904€96k€155k▲
Profit (loss) for the period to be appropriated9905€96k€155k▲
Appropriation of the result
Profit (loss) to be appropriated9906€96k€155k▲
Profit to be distributed694/7€96k€155k▲
Return on contributions (dividend)694€96k€155k▲
The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
2025
31-12
Financial
Highest result since 2019net €155k ▲62.1%
Operating result €207k, net result €155k, both a record.
30-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 30 days late
2024
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
2022
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
31-12
Financial
Weakest financial yearnet €72k ▼17.1%
Net result drops to €72k, the lowest in the series; recovery starts the following year.
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
31-12
Financial
Liquidity times 5current ratio 8.01
Current ratio from 1.46 to 8.01; short-term debt falls from €206k to €24k.
31-12
Financial
Equity above €200kEq €217k ▲42.6%
2 profitable years in a row build equity to €217k.
31-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 31 days late
2018
31-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 31 days late
2017
31-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 31 days late
2016
31-08
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Thimister-Clermont · 1 establishment unit since 2013
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Margensault 824890 Thimister-ClermontGround area
215 m²
Building footprint
216 m²
Volume, LiDAR
2,302 m³
Parcel 63077B0084/00G000, Wallonia · tallest building 22.2 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
eUrogenis
since 20132.223.120.234
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 63077B0084/00G000 | Wallonia | 215 m² | 1 · 216 m² | 22.2 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
De Lange Chirurgie Plastique
BE 0824.282.145
Ukkel · Eq €286k
Docteur maud LEBAS
BE 0820.022.756
Chaudfontaine · Eq €286k
Dr. Brozici Pneumoloog
BE 0718.896.989
Mol · Eq €287k
Dr. Nathalie Blockx
BE 0544.614.022
Sint-Katelijne-Waver · Eq €286k
Dokter Koen Slabbaert
BE 0753.473.135
Rotselaar · Eq €287k
Of 16,627 companies in sector 86220 we hold annual accounts for 7,972. 6,674 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded30-09-2013
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 11 filingsAddress and cadastre registers
Data from official sources, last processed on 18-09-2026. Scores and ratios are computed by Checked and are not a credit decision.